Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

  1. Sulzgruber, P.
  2. Wassmann, S.
  3. Semb, A.G.
  4. Doehner, W.
  5. Widimsky, P.
  6. Gremmel, T.
  7. Kaski, J.C.
  8. Savarese, G.
  9. Rosano, G.M.C.
  10. Borghi, C.
  11. Kjeldsen, K.
  12. Torp-Pedersen, C.
  13. Schmidt, T.A.
  14. Lewis, B.S.
  15. Drexel, H.
  16. Tamargo, J.
  17. Atar, D.
  18. Agewall, S.
  19. Niessner, A.
Aldizkaria:
European Heart Journal - Cardiovascular Pharmacotherapy

ISSN: 2055-6845 2055-6837

Argitalpen urtea: 2019

Alea: 5

Zenbakia: 3

Orrialdeak: 171-180

Mota: Berrikuspena

DOI: 10.1093/EHJCVP/PVZ016 GOOGLE SCHOLAR